| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT05961644 | Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). | Multiple Sclerosis, Secondary Progressive | Recruiting | 2023-07-28 |
| Not applicable | ||||
| NCT05303649 | Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia | Stroke, Ischemic | Recruiting | 2026-03-31 |
| NCT05674734 | 4FM Acceptance Training as the New Form of cPTSD-focused Treatment Based on Existential… | Trauma | Not Yet Recruiting | 2023-03-06 |
Multiple Sclerosis (1) · Stroke (1)